Cardiol Therapeutics Inc.
Sector
Industries
Location
Market Cap
USD 97.46 M
Share Price
USD 1.16
Avg Daily Volume
133,131
Change (1 day)
Change (1 year)
Change (YTD)
Eli Lilly and Company
USD 709.82
LLY
AbbVie Inc.
USD 209.50
ABBV
Roche Holding AG
USD 339.30
RO.SW
Novartis AG
USD 127.19
NOVN.SW
Novo Nordisk A/S
USD 55.23
NOVO-B.CO
AstraZeneca PLC
USD 150.15
AZN.L
Merck & Co., Inc.
USD 86.08
MRK
Thermo Fisher Scientific Inc.
USD 483.76
TMO
Amgen Inc.
USD 295.76
AMGN
Pfizer Inc.
USD 25.74
PFE
Gilead Sciences, Inc.
USD 116.14
GILD
Sanofi
USD 101.52
SAN.PA
Vertex Pharmaceuticals Incorporated
USD 397.46
VRTX
Bristol-Myers Squibb Company
USD 48.43
BMY
Chugai Pharmaceutical Co., Ltd.
USD 42.04
4519.T
Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
---|
Eli Lilly and Company
USD 709.82
LLY
AbbVie Inc.
USD 209.50
ABBV
Roche Holding AG
USD 339.30
RO.SW
Novartis AG
USD 127.19
NOVN.SW
Novo Nordisk A/S
USD 55.23
NOVO-B.CO
AstraZeneca PLC
USD 150.15
AZN.L
Merck & Co., Inc.
USD 86.08
MRK
Thermo Fisher Scientific Inc.
USD 483.76
TMO
Amgen Inc.
USD 295.76
AMGN
Pfizer Inc.
USD 25.74
PFE
Gilead Sciences, Inc.
USD 116.14
GILD
Sanofi
USD 101.52
SAN.PA
Vertex Pharmaceuticals Incorporated
USD 397.46
VRTX
Bristol-Myers Squibb Company
USD 48.43
BMY
Chugai Pharmaceutical Co., Ltd.
USD 42.04
4519.T